New to Camber’s Portfolio: Losartan Potassium and Hydrochlorothiazide Tablets
Camber Pharmaceuticals has launched Losartan Potassium and Hydrochlorothiazide Tablets [loe-SAR-tan poe-TAS-ee-um and hye-droe-klor-oh-THYE-a-zide], generic for Hyzaar®.
Losartan Potassium and Hydrochlorothiazide is a combination of an angiotensin II receptor blocker and diuretic indicated to:
- Treat hypertension and reduce cardiovascular risks, including stroke and myocardial infarction.
- Reduce stroke risk in patients with hypertension and left ventricular hypertrophy, though this benefit has not been demonstrated in Black patients.
Camber’s Losartan Potassium and Hydrochlorothiazide Tablets are available in:
| Strength | Size |
| 50 mg/12.5 mg | 30, 90 and 1000 ct |
| 100 mg/12.5 mg | 30, 90 and 1000 ct |
| 100 mg/25 mg | 30, 90 and 1000 ct |
Recent articles
- Camber Launches Raltegravir Tablets 400 mg
- Specialty Generics: Where Access Meets Affordability
- Buprenorphine and Naloxone Sublingual Films Added to Portfolio
- Buprenorphine and Naloxone Sublingual Tablets Added to Portfolio
- New to Camber’s Portfolio: Losartan Potassium and Hydrochlorothiazide Tablets
- NACDS TSE 2026 Event Recap





